|
US508386A
(en)
*
|
|
1893-11-07 |
|
hayworth |
|
US3906092A
(en)
*
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
US5906980A
(en)
*
|
1987-07-17 |
1999-05-25 |
Hem Research Inc. |
Treatment of hepatitis with mismatched dsRNA
|
|
US5683986A
(en)
*
|
1987-08-12 |
1997-11-04 |
Hemispherx Biopharma Inc. |
Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
|
|
US5593973A
(en)
*
|
1987-09-04 |
1997-01-14 |
Hemispherx Biopharma Inc. |
Treatment of viral hepatitis with mismatched dsRNA
|
|
US5000000A
(en)
*
|
1988-08-31 |
1991-03-19 |
University Of Florida |
Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
|
|
DE69023900T4
(de)
*
|
1989-02-24 |
1996-10-02 |
The Regents Of The University Of California, Berkeley, Calif. |
Gentechnologisch veränderte immunglobuline.
|
|
US5612035A
(en)
*
|
1989-03-21 |
1997-03-18 |
The Immune Response Corporation |
Vaccination against diseases resulting from pathogenic responses by specific T cell populations
|
|
ZA908037B
(en)
*
|
1989-10-11 |
1991-09-25 |
Hem Res Inc |
Protection from shock subsequent to injury by double-standed rnas
|
|
US5969109A
(en)
*
|
1990-02-28 |
1999-10-19 |
Bona; Constantin |
Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
|
|
US5998366A
(en)
*
|
1990-09-21 |
1999-12-07 |
The Regents Of The University Of California |
Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
|
|
US5474771A
(en)
*
|
1991-11-15 |
1995-12-12 |
The Trustees Of Columbia University In The City Of New York |
Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US5958457A
(en)
*
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
|
US6479055B1
(en)
*
|
1993-06-07 |
2002-11-12 |
Trimeris, Inc. |
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
|
|
WO1995026204A1
(en)
*
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
CA2194907A1
(en)
*
|
1994-07-13 |
1996-02-01 |
Kouji Matsushima |
Reshaped human antibody against human interleukin-8
|
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
ATE509102T1
(de)
*
|
1994-07-15 |
2011-05-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
|
US5698679A
(en)
*
|
1994-09-19 |
1997-12-16 |
National Jewish Center For Immunology And Respiratory Medicine |
Product and process for targeting an immune response
|
|
US5736524A
(en)
*
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
GB9501079D0
(en)
*
|
1995-01-19 |
1995-03-08 |
Bioinvent Int Ab |
Activation of T-cells
|
|
AU3583797A
(en)
*
|
1996-06-28 |
1998-01-21 |
Regents Of The University Of California, The |
Enhancement of cancer cell death
|
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU7690898A
(en)
*
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
|
US6777546B2
(en)
*
|
1997-10-07 |
2004-08-17 |
Loma Linda University |
Methods and substances for preventing and treating autoimmune disease
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
KR20000034847A
(ko)
*
|
1998-11-17 |
2000-06-26 |
성재갑 |
인간 4-1비비 분자에 대한 인간화 항체 및 이를 포함하는 약학조성물
|
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
|
DE10100586C1
(de)
*
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
|
EP1286226B1
(en)
*
|
2000-05-25 |
2008-02-27 |
Fuji Xerox Co., Ltd. |
Toner and image forming method
|
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
|
US6811785B2
(en)
*
|
2001-05-07 |
2004-11-02 |
Mount Sinai School Of Medicine Of New York University |
Multivalent MHC class II—peptide chimeras
|
|
CA2464889A1
(en)
*
|
2001-11-02 |
2003-05-08 |
Sekisui Chemical Co., Ltd. |
Cytokine-inducing material and cytokine-inducing instrument
|
|
JP2005526778A
(ja)
*
|
2002-03-15 |
2005-09-08 |
アストラル，インコーポレイテッド |
免疫調節性非コードｒｎａモチーフを用いて抗体及び主要組織適合性クラスｉ拘束性又はクラスｉｉ拘束性ｔ細胞の応答を開始或いは増強させるための組成物及び方法
|
|
WO2004037284A1
(en)
*
|
2002-10-22 |
2004-05-06 |
Sanofi Pasteur Limited |
Anti-cancer vaccines and high-dose cytokines as adjuvants
|
|
US20060172959A1
(en)
*
|
2003-03-26 |
2006-08-03 |
Dan Smith |
Selected rna motifs to include cell death and/or apoptosis
|
|
ATE511859T1
(de)
*
|
2004-07-20 |
2011-06-15 |
Schering Corp |
Apoptoseinduktion in toll-artige rezeptoren exprimierenden tumorzellen
|
|
CA2587676A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|